Clinical trial
Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris
NCT00160394 · Stiefel, a GSK Company, Industry · Completed
Key facts
| NCT number | NCT00160394 |
|---|---|
| Title | Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris |
| Official title | Multi-Centre, Single-Blind, Parallel Group, Clinical Evaluation of the Efficacy and Safety of Duac® Gel And Differin® Gel in the Topical Treatment of Mild to Moderate Acne Vulgaris |
| Lead sponsor | Stiefel, a GSK Company, Industry |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acne Vulgaris |
| Intervention type | Drug |
| Interventions | Duac® Gel / Differin® Gel |
| Enrollment | 130 |
| Start date | Dec 1, 2004 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | May 30, 2017 |
| Countries | Poland, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: